具有里程碑意义的NHS-Galleri试验取得突破性成果。数据显示,该检测方法显著降低了IV期癌症的诊断比例。同时,针对致命性癌症的早期筛查能力大幅提升——I期和II期癌症检出率明显增加。更令人瞩目的是,整体癌症检测灵敏度达到常规方法的四倍以上。这项突破为癌症早筛领域带来全新可能。
具有里程碑意义的NHS-Galleri试验取得突破性成果。数据显示,该检测方法显著降低了IV期癌症的诊断比例。同时,针对致命性癌症的早期筛查能力大幅提升——I期和II期癌症检出率明显增加。更令人瞩目的是,整体癌症检测灵敏度达到常规方法的四倍以上。这项突破为癌症早筛领域带来全新可能。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.